anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Problem Agitate Solution

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 26,550
Current window 19,621-19,650
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all
18 30 60

Arc

19,621-19,650 of 26,550

filter-aware
05
The slide uses a structured layout to present three key pillars of clinical success: efficacy, functional outcome, and safety.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
06
The slide uses a process flow diagram to illustrate the clinical trial phases (randomization, treatment, extension).Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
07
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
08
The table displays mean, standard deviation, median, and range for various clinical metrics including Plasma Arginine, GMFCS level, GMFM-E, and 2MWT.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
09
The chart is a box-and-whisker plot comparing pegzilarginase and placebo groups against clinical guidelines and normal ranges.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
10
Clinical trial data showing efficacy of pegzilarginase.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
18
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
08
The slide uses a structured layout to contrast industry metrics with the underlying scientific challenges.BenevolentAI | SPAC Presentation Deck | 42 slides · BenevolentAI
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide combines company background, team metrics, pipeline highlights, and a numbered list of platform value drivers.BenevolentAI | SPAC Presentation Deck | 42 slides · BenevolentAI
Pitch deck Investment bank Beat · AgitateLoop · Cost Of Inaction1 hit
12
The slide uses a process diagram to show the workflow and a callout box to list benefits.BenevolentAI | SPAC Presentation Deck | 42 slides · BenevolentAI
Pitch deck Investment bank Beat · Solution1 hit
01
Slide 1
Includes corporate branding, presenter name, title, and date.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Setup1 hit
02
Includes reference to SEC filings and GAAP/non-GAAP reporting policy.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Setup1 hit
03
The slide uses a simple additive diagram to explain the components of EPS growth.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
04
The slide uses a scatter plot to show correlation between growth and valuation, and a bar chart to show relative growth rates.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
The chart uses a Marimekko-style layout to visualize revenue contribution vs growth rates.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
24
Chimerix | Investor Conference Presentation Deck | 32 slidesChimerix | Investor Conference Presentation Deck | 32 slides · Chimerix
Conference presentation Investor relations Beat · Solution1 hit
26
RANO-HGG refers to Response Assessment in Neuro-Oncology for High-Grade Gliomas. BICR refers to Blinded Independent Central Review.Chimerix | Investor Conference Presentation Deck | 32 slides · Chimerix
Conference presentation Investor relations Beat · Solution1 hit
27
The plot shows individual patient responses; asterisks indicate change > 100%.Chimerix | Investor Conference Presentation Deck | 32 slides · Chimerix
Conference presentation Investor relations Beat · Solution1 hit
28
The slide uses a dual-axis line chart to correlate tumor size reduction with performance status improvement, supported by longitudinal MRI scans.Chimerix | Investor Conference Presentation Deck | 32 slides · Chimerix
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
29
The slide uses a longitudinal chart to track three metrics over 18 months alongside MRI scans.Chimerix | Investor Conference Presentation Deck | 32 slides · Chimerix
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
30
The slide compares two different RANO criteria (HGG vs LGG) for the same patient cohort to demonstrate clinical response.Chimerix | Investor Conference Presentation Deck | 32 slides · Chimerix
Conference presentation Investor relations Beat · Solution1 hit
31
The table highlights that RANO responders show significantly higher PFS and OS rates compared to non-responders.Chimerix | Investor Conference Presentation Deck | 32 slides · Chimerix
Conference presentation Investor relations Beat · Solution1 hit
32
The slide presents clinical trial data (ORR, DOR, PFS, OS) using RANO-HGG and RANO-LGG criteria.Chimerix | Investor Conference Presentation Deck | 32 slides · Chimerix
Conference presentation Investor relations Beat · Solution1 hit
07
The chart uses a baseline to show negative growth in Q1/Q2 and positive growth in Q3/Q4.Paysafe | Results Presentation Deck | 31 slides · Paysafe
Conference presentation Investor relations Beat · Desire1 hit
08
Includes a pie chart indicating the combined revenue share of these segments.Paysafe | Results Presentation Deck | 31 slides · Paysafe
Conference presentation Investor relations Beat · Desire1 hit
09
The slide uses a two-column layout to highlight specific achievements in two distinct business areas.Paysafe | Results Presentation Deck | 31 slides · Paysafe
Conference presentation Investor relations Beat · Desire1 hit
10
The slide uses a split-column layout to highlight two distinct strategic pillars.Paysafe | Results Presentation Deck | 31 slides · Paysafe
Conference presentation Investor relations Beat · Interest1 hit
11
The slide uses a hub-and-spoke diagram to represent the business model and a list to show strategic progress.Paysafe | Results Presentation Deck | 31 slides · Paysafe
Conference presentation Investor relations Beat · Interest1 hit
21
The table includes financial metrics like Revenue, Gross Profit, Adj. EBITDA, and Cost of Services with their respective margins and growth rates.Paysafe | Results Presentation Deck | 31 slides · Paysafe
Conference presentation Investor relations Beat · Action1 hit
22
The slide uses directional arrows to indicate the impact of specific business drivers on the financial outlook.Paysafe | Results Presentation Deck | 31 slides · Paysafe
Conference presentation Investor relations Beat · Action1 hit